CrosbyJ, PelosoGM, AuerPL, et al.Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med, 2014; 371:22–31.
2.
JorgensenAB, Frikke-SchmidtR, NordestgaardBG, et al.Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N Engl J Med, 2014; 371:32–41.
3.
PollinTI, DamcottCM, ShenH, et al.A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science, 2008; 322:1702–1705.
4.
GinsbergHN, LeNA, GoldbergIJ, et al.Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest, 1986; 78:1287–1295.
5.
NorumRA, ForteTM, AlaupovicP, et al.Clinical syndrome and lipid metabolism in hereditary deficiency of apolipoproteins A-I and C-III, variant 1. Adv Exp Med Biol, 1986; 201:137–149.
6.
van DijkKW, RensenPC, VosholPJ, et al.The role and mode of action of apolipoproteins CIII and AV: Synergistic actors in triglyceride metabolism?. Curr Opin Lipidol, 2004; 15:239–246.
7.
QinW, SundaramM, WangY, et al.Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: Evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen. J Biol Chem, 2011; 286:27769–27780.
8.
SundaramM, ZhongS, Bou KhalilM, et al.Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. J Lipid Res, 2010; 51:1524–1534.
9.
SundaramM, ZhongS, Bou KhalilM, et al.Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions. J Lipid Res, 2010; 51:150–161.
10.
ZannisVI, KanHY, KritisA, et al.Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo. Curr Opin Lipidol, 2001; 12:181–207.
11.
GaudetD, BrissonD, TremblayK, et al.Targeting APOC3 in the familial chylomicronemia syndrome. N Engl J Med, 2014; 371:2200–2206.
12.
GangabadageCS, ZdunekJ, TessariM, et al.Structure and dynamics of human apolipoprotein CIII. J Biol Chem, 2008; 283:17416–17427.
13.
MadejT, AddessKJ, FongJH, et al.MMDB: 3D structures and macromolecular interactions. Nucleic Acids Res, 2011; 40(Database Issue):D461–D464.
